美国 · 财经报刊 · Investor's Business Daily
Harmony Biosciences Grapples With A Leadership Transition That Spooked Investors
Harmony Biosciences remains under pressure since the company announced its CEO transition. Will an upcoming narcolepsy drug change that? The post Harmony Biosciences Grapples With…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
